IGF2 and hepatocellular carcinoma: HBx up-regulates the expression of insulin-like growth factor-II (IGF-II) in premalignant proliferative nodules [9] and type I IGF receptor (IGFIR) in hepatoma cell lines [10], implying that HBx may set up an autocrine loop [11] that enhances cell growth independent of other serum growth factors.